Breaking News

Driver under the influence crashes into two Palm Springs businesses Mental Health Clinic Serving LGBTQ Community Fights Against Unjust Eviction Usyk defeats Fury to claim undisputed heavyweight champion title | Boxing Update Three foreign citizens arrested in Iran for alleged membership in “Satanic cult”, leading to widespread arrests How the latest Android anti-theft feature protects your phone from thieves and locks it down

Researchers from Fudan University’s Eye, Ear, Nose, and Throat Hospital have successfully used genome-editing technology to control a common eye disease that affects up to 10 percent of the global population and can lead to blindness in patients. The team utilized advanced gene editing technology to develop a CRISPR/Cas9 system targeting VEGFA, which plays a significant role in inflammatory corneal neovascularization.

By inhibiting the expression of VEGFA, they were able to effectively control the disease as evidenced by successful animal experiments. The research findings were published in the prestigious journal Advanced Science. Gene editing technologies allow scientists to modify an organism’s DNA by adding, removing or altering genetic material at specific locations in the genome. Dr. Zhou Xingtao, a key researcher in the study believes this breakthrough in gene editing offers a new strategy for treating corneal neovascularization and provides a foundation for future treatments in this field.

Leave a Reply